These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 34699027)

  • 41. SRY-Box 21 Antisense RNA 1 Knockdown Diminishes Amyloid Beta
    Gu F; Ji D; Ni H; Chen D
    Neurochem Res; 2021 Sep; 46(9):2376-2386. PubMed ID: 34146195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.
    Kashour T; Burton T; Dibrov A; Amara FM
    Biochem J; 2003 Mar; 370(Pt 3):1063-75. PubMed ID: 12472467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Schizandrol A protects against Aβ
    Song L; Yao L; Zhang L; Piao Z; Lu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1739-1752. PubMed ID: 31900522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer's disease models.
    Zhang B; Wang Y; Li H; Xiong R; Zhao Z; Chu X; Li Q; Sun S; Chen S
    Drug Des Devel Ther; 2016; 10():1335-43. PubMed ID: 27103787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease.
    Castri P; Iacovelli L; De Blasi A; Giubilei F; Moretti A; Tari Capone F; Nicoletti F; Orzi F
    Eur J Neurosci; 2007 Nov; 26(9):2469-72. PubMed ID: 17986027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
    Sotolongo K; Ghiso J; Rostagno A
    Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance of Erk1/2-PI3K/Akt signaling pathway in CEES-induced oxidative stress regulates inflammation and apoptosis in keratinocytes.
    Sabnam S; Pal A
    Cell Biol Toxicol; 2019 Dec; 35(6):541-564. PubMed ID: 30805762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy.
    Fan S; Zhang B; Luan P; Gu B; Wan Q; Huang X; Liao W; Liu J
    Biomed Res Int; 2015; 2015():161020. PubMed ID: 26583091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
    Shafi O
    BMC Neurol; 2016 Nov; 16(1):236. PubMed ID: 27875990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of α7nAChR in the Protective Effects of Genistein Against β-Amyloid-Induced Oxidative Stress in Neurons via a PI3K/Akt/Nrf2 Pathway-Related Mechanism.
    Guo J; Yang G; He Y; Xu H; Fan H; An J; Zhang L; Zhang R; Cao G; Hao D; Yang H
    Cell Mol Neurobiol; 2021 Mar; 41(2):377-393. PubMed ID: 33215356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isorhapontigenin prevents β‑amyloid‑associated cognitive impairments through activation of the PI3K/AKT/GSK‑3β pathway.
    Ma Q; Li C; He Y; Liu P; Gong F; Zhang W
    Acta Neurobiol Exp (Wars); 2022; 82(3):389-397. PubMed ID: 36214721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of microRNA-196a improves cognitive impairment and alleviates neuronal damage in hippocampus tissues of Alzheimer's disease through downregulating LRIG3 expression.
    Yang K; Feng S; Ren J; Zhou W
    J Cell Biochem; 2019 Oct; 120(10):17811-17821. PubMed ID: 31119777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease.
    Akhtar A; Sah SP
    Neurochem Int; 2020 May; 135():104707. PubMed ID: 32092326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.
    Kim W; Noh H; Lee Y; Jeon J; Shanmugavadivu A; McPhie DL; Kim KS; Cohen BM; Seo H; Sonntag KC
    Mol Neurobiol; 2016 Jan; 53(1):95-108. PubMed ID: 25407931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.
    Feng HL; Dang HZ; Fan H; Chen XP; Rao YX; Ren Y; Yang JD; Shi J; Wang PW; Tian JZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):734-741. PubMed ID: 27466310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K/Akt/GLT-1 axis.
    Cao H; Zuo C; Gu Z; Huang Y; Yang Y; Zhu L; Jiang Y; Wang F
    Redox Biol; 2022 Aug; 54():102354. PubMed ID: 35660628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.